Plain-English translation of NCT06481306 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This is an early-stage research study testing a new drug called in people with sickle cell disease. The study will first check if the medication is safe and well-tolerated, then look at how the body processes it and whether it may help reduce pain crises. Researchers will also test how food and stomach acid affect the medication.
Sickle cell disease causes severe, unpredictable pain crises that can land patients in the hospital for days. Current treatments don't work well enough for everyone. This trial is exploring whether this new medication could offer a better way to prevent or reduce these painful episodes.
You likely qualify if…
You likely don't qualify if…
You will be assigned to receive either the new medication or a placebo (a dummy pill with no active ingredient) in a randomized fashion—meaning the assignment is decided by chance and neither you nor the researchers will initially know which you're receiving. Over several visits, the study team will check your blood work, vital signs, and how you're feeling. Depending on the study phase, you may also complete special tests to see how food and stomach acid affect the medication. The study will help researchers understand whether this treatment is safe and whether it might reduce the number and severity of your pain crises.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States